Targeting the MAPK Pathway for NRAS Mutant Melanoma: From Mechanism to Clinic

The authors summarize advances in the direct targeting of mutant NRAS proteins and their downstream RAF and MEK proteins, as well as targeting the MAPK pathway in combination with other therapeutic targets to treat NRAS mutant melanoma.